Benzinga
Benzinga
Benzinga
samedi, septembre 26

Prime Medicine Inc

PRMENASDAQ
Trade with Public
Trade with Public
$2.90
-0.17-5.54%
À la clôture: Sep 25, 5:00 PM EST
$2.95
0.05381.86%
Après les heures: 7:58 PM EST
PRO
Pourquoi cela bouge-t-il ?:Prime Medicine shares are trading higher after the company announced the FD...
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatDividendesComparerOptionsRapport sur les stocks

Prime Medicine Financials

Prime Medicine (PRME) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Costco Wholesale, Scholastic and 3 Stocks to Watch Heading Into Friday

Scholastic fell on weak results, Costco beat estimates, Prime Medicine gained on FDA clearance, and INLIF surged on revenue growth.
Avi Kapoor

PRO
Prime Medicine Q2 EPS $(0.24) Beats $(0.26) Estimate, Sales $1.154M Miss $1.295M Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 41.46 percent increase over losses of $(0.41) per share from
Benzinga Newsdesk

PRO
Prime Medicine Q1 EPS $(0.28) Misses $(0.25) Estimate, Sales $856.000K Miss $1.065M Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.25) by 12 percent. This is a 30 percent increase over losses of $(0.40) per share from the
Benzinga Newsdesk

PRO
Prime Medicine Expects That Its Cash, Cash Equivalents And Investments Of $213.3M As Of September 30, 2025 Will Be Sufficient To Fund Its Operating Expenses And Capital Expenditure Requirements Into 2027.

Benzinga Newsdesk

PRO
Prime Medicine Q3 EPS $(0.32) Misses $(0.26) Estimate, Sales $1.225M Beat $1.026M Estimate

Benzinga Newsdesk

PRO
Prime Medicine Q2 EPS $(0.41) Misses $(0.39) Estimate, Sales $1.115M Beat $750.000K Estimate

Prime Medicine (NASDAQ:PRME) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.39) by 6.22 percent. This is a 10.87 percent increase over losses of $(0.46) per share from
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved